0001209191-20-035636.txt : 20200610
0001209191-20-035636.hdr.sgml : 20200610
20200610174130
ACCESSION NUMBER: 0001209191-20-035636
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Serbousek Jon Carl
CENTRAL INDEX KEY: 0001536875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19961
FILM NUMBER: 20955601
MAIL ADDRESS:
STREET 1: C/O BIOMET, INC.
STREET 2: P.O. BOX 587
CITY: WARSAW
STATE: IN
ZIP: 46581-0587
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orthofix Medical Inc.
CENTRAL INDEX KEY: 0000884624
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
BUSINESS PHONE: 214-937-2000
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOFIX INTERNATIONAL N V
DATE OF NAME CHANGE: 19970708
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-08
0
0000884624
Orthofix Medical Inc.
OFIX
0001536875
Serbousek Jon Carl
3451 PLANO PARKWAY
LEWISVILLE
TX
75056
1
1
0
0
CEO
Performance Share Units
0.00
2020-06-08
4
A
0
45872
0.00
A
Common Stock
45872
45872
D
Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.
/s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney
2020-06-10